P. Masarachia

Alendronate mechanism of action: geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation <i>in vitro</i>

John Fisher, Michael J. Rogers, J. M. Halasy et al. · Proceedings of the National Academy of Sciences · 1999 · 679 citations

Sclerostin, Bone Resorption, Macrophage Apoptosis +17

Alendronate Is a Specific, Nanomolar Inhibitor of Farnesyl Diphosphate Synthase

James D. Bergstrom, Richard G. Bostedor, P. Masarachia et al. · Archives of Biochemistry and Biophysics · 2000 · 398 citations

Biochemistry, Natural Sciences, Biocatalysis +6

Bisphosphonates Act Directly on the Osteoclast to Induce Caspase Cleavage of Mst1 Kinase during Apoptosis

Alfred A. Reszka, Judit Halasy-Nagy, P. Masarachia et al. · Journal of Biological Chemistry · 1999 · 256 citations · Full text

Comparison of the distribution of 3H-alendronate and 3H-Etidronate in rat and mouse bones

P. Masarachia, Miron Weinreb, R. Balena et al. · Bone · 1996 · 248 citations

Mechanobiology, Mouse Bones, Bone Health +12

Bone density, strength, and formation in adult cathepsin K (−/−) mice

Brenda L Pennypacker, M. Shea, Q. Liu et al. · Bone · 2008 · 145 citations

Animal Physiology, Mechanobiology, Physiology +11